Onconetix, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
ONCO Company Description
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
ONCO Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view ONCO Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of ONCO by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ONCO's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of ONCO in WallStreetBets Daily Discussion
ONCO News
Recent insights relating to ONCO
CNBC Recommendations
Recent picks made for ONCO stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in ONCO
Corporate Flights
Flights by private jets registered to ONCO
Our Analysis